| Database of p53 gene somatic mutations in human tumors and cell lines. M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sørlie, E Hovig, ... Nucleic acids research 22 (17), 3551, 1994 | 1349 | 1994 |
| A literature network of human genes for high-throughput analysis of gene expression TK Jenssen, A Lægreid, J Komorowski, E Hovig Nature genetics 28 (1), 21-28, 2001 | 1113 | 2001 |
| Ten simple rules for reproducible computational research GK Sandve, A Nekrutenko, J Taylor, E Hovig PLoS computational biology 9 (10), e1003285, 2013 | 754 | 2013 |
| Somatic Point Mutations in the p53 Gene of Human Tumors and Cell Lines: Updated Compilation M Hollstein, B Shomer, M Greenblatt, T Soussi, E Hovig, R Montesano, ... Nucleic acids research 24 (1), 141-146, 1996 | 684 | 1996 |
| A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome B Fromm, T Billipp, LE Peck, M Johansen, JE Tarver, BL King, ... Annual review of genetics 49, 213-242, 2015 | 514 | 2015 |
| Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 66 (3), 464-472, 2017 | 510 | 2017 |
| Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 67 (7), 1306-1316, 2018 | 499 | 2018 |
| Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ... Genetics in Medicine 22 (1), 15-25, 2020 | 409 | 2020 |
| Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects P Hainaut, T Soussi, B Shomer, M Hollstein, M Greenblatt, E Hovig, ... Nucleic acids research 25 (1), 151-157, 1997 | 404 | 1997 |
| A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing TS Alioto, I Buchhalter, S Derdak, B Hutter, MD Eldridge, E Hovig, ... Nature communications 6 (1), 1-13, 2015 | 308 | 2015 |
| Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses V Nygaard, EA Rødland, E Hovig Biostatistics 17 (1), 29-39, 2016 | 292 | 2016 |
| Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells P Ruud, Ø Fodstad, E Hovig International journal of cancer 80 (1), 119-125, 1999 | 248 | 1999 |
| Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma GM Maelandsmo, VA Flørenes, T Mellingsaeter, E Hovig, RS Kerbel, ... International journal of cancer 74 (4), 464-469, 1997 | 248 | 1997 |
| Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. AL Børresen, E Hovig, B Smith-Sørensen, D Malkin, S Lystad, ... Proceedings of the National Academy of Sciences 88 (19), 8405-8409, 1991 | 248 | 1991 |
| Screening for Germ Line TP53 Mutations in Breast Cancer Patients AL Børresen, TI Andersen, J Garber, N Barbier-Piraux, S Thorlacius, ... Cancer research 52 (11), 3234-3236, 1992 | 240 | 1992 |
| S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti … K Bjørnland, JO Winberg, OT Ødegaard, E Hovig, T Loennechen, ... Cancer research 59 (18), 4702-4708, 1999 | 222 | 1999 |
| TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ... Genes, Chromosomes and Cancer 14 (1), 71-75, 1995 | 212 | 1995 |
| Performance comparison of four exome capture systems for deep sequencing CSR Chilamakuri, S Lorenz, MA Madoui, D Vodák, J Sun, E Hovig, ... BMC genomics 15, 1-14, 2014 | 197 | 2014 |
| MirGeneDB 2.0: the metazoan microRNA complement B Fromm, D Domanska, E Høye, V Ovchinnikov, W Kang, ... Nucleic Acids Research 48 (D1), D132-D141, 2020 | 191 | 2020 |
| A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies WP Kuo, F Liu, J Trimarchi, C Punzo, M Lombardi, J Sarang, ME Whipple, ... Nature biotechnology 24 (7), 832-840, 2006 | 190 | 2006 |
Ola MyklebostProfessor Cancer Biology, University of BergenVerified email at uib.no
